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Since the description of the in vivo allogeneic effect in inbred guinea pigs (1-3) and 
more recent extension of the system to inbred mice (4-7), considerable attention has 
been focused on this phenomenon as a model of the regulatory mechanisms of activated 
T  lymphocytes on  immune responses in  vivo  (for reviews, see references 8  and 9). 
The allogeneic effect, as first described, demonstrated that the transfer of allogeneic 
immunocompetent lymphoid cells to animals previously primed with a hapten-carrier 
conjugate,  such  as 2,4-dinitrophenyl  (DNP)-keyhole  limpet  hemocyanin  (KLH),  1 
markedly enhanced  the  antihapten  antibody  response  to  an  appropriately timed 
secondary challenge with  that hapten coupled to an unrelated carrier. This phenom- 
enon has been  shown  to require  the  initiation  of  an  active  graft-vs.-host  (GVH) 
reaction in the lymphoid tissues of the primed host (1) and to reflect the direct inter- 
action of donor T  lymphocytes recognizing foreign histocompatibility determinants 
on primed host B lymphocytes, irrespective of the presence of host T  cells (5). There 
appeared to be an absolute requirement that the host hapten-specific lymphocytes be 
primed before establishing the  GVH reaction, and attempts to demonstrate an en- 
hanced primary antibody response to a wide variety of immunogens were unsuccessful 
(1-4). More recently, in our own and other laboratories (10-12)  the capacity of the 
allogeneic effect to markedly enhance primary antibody responses, usually of the IgG 
class, to a very restricted group of functionally thymus-independent antigens has been 
clearly demonstrated. 
In the present studies, we have examined the possible regulatory effects of 
interactions of allogeneic donor T  cells with T  lymphocytes of the host. Of the 
various  specific functions  performed  by mature  T  lymphocytes, we have  as- 
sessed the capacity of carrier-primed T  cells to exert a  specific helper function 
with  hapten-primed  B  lymphocytes  in  producing  an  antihapten  antibody 
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response.  By employing a  variety of carrier molecules and priming regimens, 
we demonstrate that the transfer of allogeneic lymphoid cells during the course 
of priming of helper T  lymphocytes can significantly increase the  functional 
capacity of such T  cells when assayed in a cooperative cell transfer system with 
DNP-specific B lymphocytes. This enhancement of T  cell activity is dependent 
upon  the  number of  allogeneic cells  transferred  and  the  time-course of  the 
resultant GVH reaction. Indeed, conditions of too great or prolonged allogeneic 
stimulation result in suppression rather than enhancement of helper cell func- 
tion. Moreover, this phenomenon  reflects the interaction of allogeneic T lympho- 
cytes with the host T  lymphocytes during the phase of carrier priming, and can 
be manifested on either primed or virgin T  cell populations. 
Materials and Methods 
Proteins and Hapten-Protein Conjugates.--Bovine gamma globulin (BGG) was obtained 
from Pentex Biochemicals, Kankakee, Ill. Keyhole limpet hemocyanin (KLH) was purchased 
from Pacific Bio-Marine Supply Co., Venice, Calif. The following 2,4-dinitrophenyl  (DNP) 
conjugates were prepared as previously described (13, 14) : DNP14-KLH (the subscript refers 
to the average number of moles of DNP per 10,000 mol wt units of KLH) and DNP32-BGG 
(subscript refers to the average number of moles of DNP per mole of BGG). 
Animals, Immunizations, and Cell Transfers.--Mice of the inbred lines A/J and (BALB/c X 
A/J)F1 hybrids (CAF1) were obtained from Jackson Laboratory, Bar Harbor, Maine. Inbred 
A/St mice were purchased from West  Seneca Laboratories, Buffalo, N.  Y. All mice were 
immunized or used as recipients between 8 and 12 wk of age. 
DNP-primed  spleen cells were prepared  by immunizing CAF1 mice intraperitoneally 
(i.p.) with  100 /zg of either DNP-KLH or DNP-BGG emulsified in complete Freund's ad- 
juvant ([CFA] Difco Laboratories, Detroit, Mich.) at least 1 mo before cell transfer. Carrier- 
primed spleen cells were prepared by immunizing CAF1 mice with KLH or BGG either with 
or without the administration of parental A/J allogeneic spleen cells, as outlined in the body 
of this paper. Both DNP-primed  and carrier-primed spleen cells were prepared as single-cell 
suspensions, washed in minimal essential medium (Eagle's), mixed to a final concentration 
of 25 )<  106 hapten-primed cells and 10 X  106 carrier-primed cells, and incubated with an 
appropriate  concentration of stimulating antigen for 15 min at 4°C. This mixture was then 
injected intravenously into 550 R irradiated  syngeneic CAF1 mice. All experimental mice 
were bled 7 days after cell transfer and anti-DNP antibody determinations were performed as 
described below. 
Measurement of Anti-DNP Antibody.--Serum anti-DNP antibody levels were determined 
by a modified Farr technique (15, 16)  using  [aH]-DNP-e-amino-N-caproic  acid (13). Using 
standard curves constructed  for individual mouse strains  in a  manner identical with  that 
described previously for inbred guinea pigs (13), percentage of binding was converted into 
amount of anti-DNP antibody in micrograms per milliliter of serum. 
Statistical Analysis.--Serum  antibody levels were logarithmically transformed and geo- 
metric  means and  standard  errors  calculated.  Group  comparisons were made  employing 
Student's  t  test. 
RESULTS 
The  Enhancing  Effect  of  Allogeneic  Cell  Transfer  on  Preparation  of BGG 
Helper Cells.--In  this initial experiment helper  cells were  prepared  in CAF1 
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FIG.  1. The enhancing effect of allogeneic cell transfer  on the priming of BGG-specific 
helper  cells. CAF1 mice were primed  with  BGG according to the various regimens listed 
above.  10 X  106 spleen cells from these mice were transferred  intravenously  together with 
25 X 106 DNP-KLH-primed CAF1 spleen cells and 50/zg of DNP-BGG into 550 R irradiated 
CAF1 mice. 7 days later  the recipient mice were bled and their sera assayed for anti-DNP 
antibody. The data are expressed as geometric means of groups of five mice. A comparison of 
various groups yielded the following P  values:  (a) group I with group II, _P =  0.0112; (b) 
group I with group III, P  =  0.00003; (c) group I with group IV, P  =  0.0012; (d) group II 
with group III, Y =  0.0030; (e) group II with group IV, P  =  0.2136. 
followed 7 days later by a boosting immunization of soluble BGG either with or 
without a simultaneous intravenous injection of 25 X  106 parental A/J spleen 
cells. Thus, carrier-primed donor mice in group II were immunized with 100#g 
of BGG in CFA and boosted 7 days later with 50 #g of soluble BGG. :In group 
III,  the  latter  immunization  was  accompanied  by  the  intravenous  transfer 
of 25 X  108 parental spleen cells from unimmunized A/J donors. Group IV cell 
donors received no initial injection of BGG in CFA, but were primed with 50 #g 
of soluble BGG i.p. and simultaneously given 25 X  106 normal A/J spleen cells. 
Spleen cells from normal CAF1 donor mice substituted for BGG-primed helper 
cells in group I. 4  days after immunization with soluble BGG and  allogeneic 
cell transfer,  spleen cells from these groups of mice were transferred  together 
with  I)NP-KLH-primed  spleen  cells  plus  antigen  into  irradiated  recipients. 
7 days later these mice were bled and levels of serum anti-DNP antibody were 
measured. 
The results are illustrated in Fig. 1. Control mice that received only 25 X  106 
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developed a marked anamnestic response, producing a mean of 9,692 #g/ml of 
anti-DNP antibody3 Mice in group I, which received normal rather than BGG- 
primed spleen cells, made a negligible response to 50 #g of DNP-BGG. Mice in 
group II, which  received BGG-primed helper cells in  addition  to  the DNP- 
KLH-primed spleen cells,  made significantly higher levels of anti-DNP  anti- 
body  in  response  to  challenge  with  DNP-BGG,  clearly demonstrating  the 
"helper effect" of specifically primed T  lymphocytes (8). However, when an 
allogeneic cell transfer was added to the priming regimen of helper cells at the 
time of boosting with soluble BGG (group III) there was a marked increase in 
the  helper function of these spleen cells as  reflected by the  threefold higher 
magnitude of response to DNP-BGG in recipients of such cells. This difference 
is highly significant and clearly demonstrates that allogeneic spleen cells  can 
have  an  enhancing  effect on  the  priming  of  carrier-specific helper  T  cells. 
Furthermore, as shown in group IV, a single exposure to 50 #g of soluble BGG 
together with 25  X  106 allogeneic spleen cells 4 days before harvest of donor 
spleen cells resulted in the production of an appreciable number of helper cells 
capable of cooperating with DNP-primed cells. This finding could reflect one of 
two possibilities: either (a)  the presence of an expanded population of BGG- 
specific helper cells,  or (b) the carry-over to the irradiated CAF1 recipients of 
significant  numbers  of  allogeneic A/J  spleen  cells  that  are  then  capable  of 
abrogating the requirement for specific helper T  cells in the response of DNP- 
KLH-primed  spleen  cells  to  challenge  with  DNP-BGG,  i.e.,  the  allogeneic 
effect on primed B cells (1-4). The following experiment was designed to answer 
these questions. 
The Enhancing Effect of Allogeneic Cell Transfer on the _Preparation of KLH 
Helper  CeIls.--In  this  experiment, helper  cells were primed  with  KLH pre- 
cipitated with aluminum potassium sulfate (alum) rather than BGG emulsified 
in CFA, to insure that the phenomenon described was not limited to the BGG 
helper system and that it was not significantly influenced by the presence of 
CFA. As outlined in Fig. 2, five different immunization schemes were employed 
to prepare KLH-primed helper cells  (groups II-VI),  which were  tested in a 
double  adoptive  transfer  system  with  spleen  cells  from  DNP-BGG-primed 
donor mice. Thus, 10 X  106 KLH-primed helper cells, or normal spleen cells in 
the case of group I, 25  X  106 DNP-BGG-primed  hapten-specific  spleen  cells, 
plus 100 #g of DNP-KLH were transferred intravenously into individual 550 R 
irradiated syngeneic CAF1  mice. On  day 7 serum  anti-DNP  antibody levels 
were determined. The results are shown in Fig. 2. 
Control mice  that  received 25  X  106 DNP-BGG-primed  spleen  cells  and 
2 The conversion values from percent binding to micrograms per milliliter are relative 
rather than absolute in the case of the homologous  boost controls in these studies, since wide 
discrepancies in average antibody affinity  from those of experimental  groups are not accounted 
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FIG. 2.  The enhancing  effect of allogeneic cell transfer on the priming of KLH specific 
helper cells. CAF1 mice were primed with KLH according to the above regimens. 10 X  106 
spleen ceils from  these  mice were transferred intravenously together with 25  X  10  ~ DNP- 
BGG-primed CAF1 spleen cells and 100 #g of DNP-KLH into 550 R irradiated CAFt mice. 
7 days later the recipient mice were bled and their sera assayed for anti-DNP antibody. The 
data are expressed as geometric means of groups of five mice. A comparison of various groups 
yielded the following P values: (a) group I with group II, P  =  0.0006;  (b) group I with group 
III, 2"  =  0.00o04;  (4 group I with group IV, P  =  0.0001; (d) group I with group V, P  = 
0.0525; (e) group I with group VI, P  =  0.00007; (f) group II with group III, P  =  0.0144;" 
(g) group II with group IV, P  =  0.2523; (h) group II with group V, P  =  0.0778; (i) group 
II with group VI, P  =  0.4203. 
10  X  106  normal spleen ceils produced  a  mean  of 4,229/zg/ml  of anti-DNP 
antibody after challenge with the homologous conjugate DNP-BGG, whereas, 
recipients of the same cell mixture  (group I) made no response to the heterol- 
ogous conjugate,  DNP-KLH.  Spleen cells from  CAF1  mice  immunized  with 
100 #g of KLH  (alum) i.p. and boosted 1 wk later with 50 #g of soluble KLH 
(group  II)  provided significant helper activity when  mixed with DNP-BGG- 
primed  CAF1  spleen  cells and  challenged  with  DNP-KLH.  The  addition  of 
allogeneic spleen cells to the priming regimen at the time of boost with KLH 
resulted in a  striking fourfold increase in helper activity after challenge with 
DNP-KLH  (group III).  This  again  demonstrates  the  capacity of  allogeneic 
cells to enhance the specific priming of helper T  cells. The possibility that this 830  ALLOGENEIC  EFFECT  ON  T  CELL  FUNCTION 
enhancement is due, in any part,  to carry-over of allogeneic cells to irradiated 
recipients  is ruled out by the results shown for group V, in which CAF1 mice 
received only 25 X  10  ~ parental A/J spleen cells and at no time were exposed 
to KLH. The level of anti-DNP antibody response to DNP-KLH when spleen 
cells from these mice were mixed with DNP-BGG-primed spleen cells was not 
significantly different from the low response noted when normal  CAFs spleen 
cells were employed in place of specific KLH-primed helpers (group I). Spleen 
cells harvested  from mice only 4  days after i.p.  immunization  with  50 #g of 
soluble  KLH,  a  highly  immunogenic  molecule,  conferred  significant  helper 
activity (group VI); indeed they were as active as helper cells from primed and 
boosted mice  (group  II).  Finally,  mice receiving  allogeneic  cells and  soluble 
KLH 4 days before harvest of helper cells (group IV) also provided a significant 
level of helper activity, but this was not appreciably greater than that of cells 
from similarly primed donor mice that  did not receive allogeneic cells (group 
VI). 
Preparation  of BGG  Helper  Cells with  a  4  Day  Priming  Regimen.--One 
surprising observation in both of the preceding experiments was that a 4 day 
exposure to antigen, with or without allogeneic cells, could result in significant 
levels of helper activity (Fig.  1, group IV; Fig. 2, groups IV and VI). The fol- 
lowing experiment, illustrated in Fig. 3, was designed to investigate this effect 
more thoroughly utilizing varying conditions of BGG priming. 
As illustrated in Fig. 3, mice primed with BGG (CFA) and boosted 7 days 
later  with  soluble BGG  (group  II)  produced  helper  cells with  high  levels of 
specific functional  helper  activity.  Donor mice  that  received only allogeneic 
cells (group IV) or only soluble BGG (group V) yielded spleen cells with only 
meager helper activity. However, when allogeneic cells and soluble BGG were 
given  together  (group  III),  spleen  cells harvested  4  days later  manifested  a 
fourfold higher degree of helper activity. In contrast  to the preceding experi- 
ment  employing KLH  (Fig.  2),  the results of this  experiment  show that  ad- 
ministration of the weaker immunogen, BGG, alone fails to produce significant 
numbers of BGG helper cells in a short 4 day period. On the other hand, when 
soluble  BGG  is  given  together  with  allogeneic  cells,  there  is  a  quantifiable 
increase  in  the  level of BGG-specific helper  function  in  the  spleens  of these 
animals at 4 days (group III). 
The Enhancing and Suppressing Effects of Allogeneic Cells on BGG Helper Cell 
Priming.--This experiment was carried out to study the effect of the allogeneic 
cell dose and the time interval between allogeneic cell transfer and harvest of 
spleen cells on the development of BGG helper cells. In previous studies in both 
guinea pigs (1, 3) and inbred mice (4, 5, 10) the dose of allogeneic cells and time 
interval between cell transfer and challenge have been critical factors influencing 
the magnitude of the allogeneic effect on B cell function. Indeed, if the dose of 
cells given is too high or the interval between cell transfer and challenge is in- 
appropriate,  suppression  rather  than  enhancement  of  the  immune  response 
occurs (4, 9). DAVID P.  0SBORNE~ JR.  AND  DAVID H.  KATz  831 
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FIG. 3.  Preparation of BGG helper cells with a 4 day priming regimen. CAF1 mice were 
primed with BGG as indicated in the groups above. 10  X  106 spleen cells from these mice 
were  transferred intravenously together with 25  X  106  DNP-KLH-primed CAF1  spleen 
cells and 100 gg of DNP-BGG into 550 R  irradiated CAF1 mice. 7 days later recipient mice 
were bled and their sera assayed for anti-DNP antibody. The data are expressed as geometric 
means of groups of five mice. A comparison of various groups yielded the following P  values: 
(a) group I with group II, P  =  0.00098;  (b) group I with group III, P  =  0.0142;  (c) group I 
with group IV, P  =  0.1818;  (d) group I with group V, P  =  0.1568. 
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In  the present experiments either 5  X  l0  s  (Fig. 4)  or 25  X  106  (Fig.  5) 
parental  A/St  spleen  cells  were  transferred  to  CAF1  recipients.  On  day 0, 
CAF1 mice either received an immunization of 100/~g of BGG in CFA or were 
not immunized and served as controls. On day 0 or on day 3, mice from both 
groups were given allogeneic spleen cells intravenously. Spleens were harvested 
on either day 7 or day 11 and assayed for BGG-specific helper cell activity by 
transferring a mixture of 10  X  106 helper cells,  10 X  106 DNP-KLH-prirned 
CAFI ,pleen cells, and 100/zg of DNP-BGG intravenously into 550 R irradiated 
CAF1 mice. Serum levels of anti-DNP antibody were determined 7 days later. 
A summary of the protocols and the results of these experiments are illustrated 
in Figs. 4 and S. 
Mice  receiving  DNP-KLH-primed  spleen  cells  plus  cells  from  unprimed 
donors made low levels of anti-DNP  antibody when challenged with DNP- 
BGG (groups I, II, and III in Figs. 4 and 5). There is no evidence of carrying 
over allogeneic cells except in group III, Fig. 5, in which CAF~ mice were given 
25 X  106 A/J spleen cells 4 days before cell transfer (day 3), and in which the 
level of response is somewhat higher, though not statistically significant, than 
control (group I). Spleen cells from donor mice primed with 100 ~g of BGG in 832  ALLOGENEIC  EFFECT  ON  T  CELL  FUNCTION 
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FIG. 4. The enhancing and suppressing effects of 5 X  106 allogeneic cells on BGG helper 
cell priming. CAF1 mice were either not primed  (groups  I-III) or were primed with 100 #g 
of BGG in CFA on day 0 as shown above (groups IV-VI). 5 X  106 parental allogeneic A/St 
spleen cells were then transferred to the groups as indicated on either day 0 or day 3.  10 X 
106 spleen cells from these mice, removed on day 7 or day 11, were transferred intravenously 
together with 10 X  106 DNP-KLH-primed CAF1 spleen cells and 100/zg of DNP-BGG into 
550  R  irradiated syngeneic CAF1 recipients.  7 days later recipient mice were bled and  sera 
assayed  for anti-DNP  antibody.  The data  are expressed  as geometric means of groups  of 
five mice. A  comparison of various groups yielded the following P  values: On day  7:  (a) 
group  I  with group II, P  =  0.2720;  (b)  group  I  with group  III, P  =  0.5038;  (c) group I 
with group IV, P  =  0.0023;  (d) group I  with group V, P  =  0.0041;  (e) group I  with group 
VI, P  =  0.0024;  (f) group IV with group V, P  =  0.8138;  (g) group IV with group VI, P  = 
0.5955.  On day 11: (a) group I  with group II, P  =0.6744;  (b) group I with group  III, P  = 
0.4615;  (c) group I  with group IV, P  =  0.0008;  (d) group I  with group V, -P  =  0.0051;  (e) 
group I  with group VI, P  =  0.0559;  (f) group IV with group V, P  =  0.0063;  (g) group IV 
with  group  VI,  P  =  0.0179. 
CFA,  manifested  a  good degree  of helper  activity when  transferred  either  on 
day 7 or day  11  (group IV, Figs. 4  and 5).  The administration  of parental A/J 
spleen  cells  resulted  in  a  significant  enhancement  of  BGG  helper  activity of 
donor spleen cells, provided:  (a)  the allogeneic cells were given on day 3  after 
priming;  (b)  the  spleens  were harvested  4  days  later  (day  7);  and  (c)  an  ap- 
propriate  amount of allogeneic cells (25  X  106)  were employed. This is demon- 
strated  by part  of group VI, Fig. 5.  In contrast,  transfer of 5  X  106 allogeneic DAVID  P.  OSBORNE~  JR.  AND  DAVID  H.  KATz  833 
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FIG. 5. The enhancing and suppressing effects of 25  X  106 allogeneic cells on BGG helper 
cell priming. The protocol is as described in Fig. 4, employing 25  X  106 allogeneic cells. The 
data are expressed as geometric means of groups of five mice. A  comparison of various groups 
yielded the following P  values: On day 7: (a) group I  with group II, P  =  0.2806;  (b) group 
I with group III, P  =  0.0805; (c) group I with group IV, P  =  0.0023;  (d) group I with group 
V, P  =  0.0107;  (e) group I  with group VI, P  =  0.0004;  (f) group IV with group V, P  = 
0.0457;  (g) group IV with group VI, P  =  0.0257. On day 11: (a) group I with group II, P  = 
0.7696;  (b)  group I  with group III, P  =  0.1622;  (c)  group I  with group IV, P  =  0.0008; 
(d) group I  with group V, P  =  0.0373;  (e)  group I  with group VI, P  =  0.1052;  (f) group 
IV with group V, P  =  0.0042; (g) group IV with group VI, P  =  0.00004. 
cells failed to enhance BGG helper function when donor spleens were harvested 
on day 7, irrespective of when during the priming regimen parental cells were 
administered (groups V  and VI, Fig. 4), indicating that this is a  suboptimal 
dose of allogeneic cells for expression of the allogeneic effect in an enhancing 
fashion on T  cell function. This is consistent with findings previously reported 
for the allogeneic effect on primed and unprimed mouse B lymphocytes (4, 10) 
in which the optimal dose of allogeneic cells was 25 X  106. 
Perhaps  most striking, however,  are  the results obtained when the helper 
spleen cells were harvested on day 11. BGG-specific helper cells prepared by 
immunization with 100/zg of BGG in CFA (group IV) and harvested on day 11 
cooperated  as  well  as  those harvested  on day 7.  In  contrast,  BGG-primed 
helper cells prepared in the presence of allogeneic cells and harvested on day 11 834  ALLOGENEIC  EFFECT  ON  T  CELL  FUNCTION 
(groups V and VI, Figs. 4 and 5) were totally incapable of supplying any helper 
activity. It appears  that,  by day 11,  the allogeneic cells  have had a  strong 
suppressive  effect on the function of BGG-specific helper T  cells,  and have 
greatly diminished their ability to cooperate in this transfer system. Moreover, 
whereas 5 X  106 allogeneic  cells failed to enhance the priming of BGG helper 
cells  (Fig. 4),  they were as potent as 25  X  10  ~ allogeneic cells in suppressing 
BGG helper cell function by day 11  (groups V and VI). Some suppression of 
BGG helper cell function was even somewhat evident when donor spleen cells 
from recipients of 25  X  106 parental cells on day 0 were harvested on day 7 
(group V, Fig. 5). These allogeneic effects on the priming of T lymphocytes for 
helper function parallel our previous findings noted for the allogeneic effect on 
primed B lymphocytes (1, 3, 4, 8, 9) in which the transfer of allogeneic cells was 
found to be enhancing or suppressive depending on the time interval employed 
between the transfer of allogeneic cells and administration of secondary chal- 
lenge. 
DISCUSSION 
The  bulk  of previous  experimentation  on  the  allogeneic  effect has  dealt 
primarily with  enhancing and  suppressive  influences exerted  directly on  B 
lymphocytes (8, 9). Accordingly, relatively little is known about what various 
effects  a  transient  GVH  reaction  might  have  on  T  cell-mediated  immune 
responses in the host animal. There is some indirect evidence that the allo- 
geneic effect may have an enhancing influence on cell-mediated immunity that 
derives from recent studies in which the highly fatal course of acute lympho- 
cytic leukemia (L2C) in inbred strain 2 guinea pigs was significantly altered 
after induction of a transient GVH reaction (17, 18). Since detailed studies of 
immunity induced to  this particular leukemia have  demonstrated that it is 
predominantly a cell-mediated immunity (19), it is possible that the protection 
observed  during  the  allogeneic  effect reflected enhancement of specific  cell- 
mediated immune reactivity in such animals. Another line of evidence for the 
allogeneic effect influencing host T cell function stems from studies reported by 
McBride et al. several years ago on the transferability of GVH splenomegaly in 
chick embryos (20). These investigators found that the 17-day embryo recipient 
of adult immunocompetent lymphocytes undergoes  an  accelerated immuno- 
logical maturation that in 7 days confers upon its lymphoid cells an unusually 
high degree of immunocompetence as reflected by their capacity to induce a 
GVH reaction in a new host embryo (20). Careful analysis of their data leaves 
little doubt that what they observed represented the allogeneic effect on a T 
cell-mediated immune response. 
The studies presented herein were designed to directly evaluate the effects of 
a  transient GVH reaction on T  lymphocyte functions. To this end, we have 
shown that generation of carrier-specific  helper cell function can be significantly 
influenced by the allogeneic effect. Thus, carrier-primed helper cells specific for DAVID  P.  OSBORNE,  JR.  AND  DAVID  H.  KATZ  835 
either KLH or BGG derived from CAF1 donor mice were generally much more 
active in specifically cooperating with syngeneic DNP-primed B cells in adop- 
tive recipients when parental A strain lymphocytes had been administered at 
some time during the priming regimen (Figs.  1-3).  This was true when allo- 
geneic cells were administered concomitantly with the initial priming dose of 
carrier protein as well as when the GVH was induced in animals that had been 
exposed to antigen several days previously. This indicates that the allogeneic 
enhancing effects can be manifested on either primed or unprimed T cell popu- 
lations. 
The ultimate effect of the GVH reaction on the development of helper T cell 
activity was found to be related to the number of allogeneic cells employed and 
the duration of the resultant GVH reaction in the carrier-primed host animal. 
Hence,  allogeneic  stimulation  of  slightly greater  magnitude  and/or  longer 
duration resulted in marked suppression rather than enhancement of helper cell 
function in such donor mice. In these studies, prolonged allogeneic stimulation 
completely suppressed  the  capacity of carrier-primed  donor cells  to  exert  a 
helper effect (group VI, day 11, Figs. 4 and 5) when a dose of 25 >( 106 allogeneic 
cells was employed in their preparation, while helper cells prepared in an identi- 
cal manner but harvested from donor mice a few days earlier manifested en- 
hanced helper cell function (group VI, day 7, Fig. 5). On the other hand, neither 
enhancement nor suppression of helper activity was noted when a low dose of 
allogeneic cells was employed (5 X  106) and cells were harvested on day 7 after 
carrier priming, whereas by day 11 this dose of allogeneic cells was comparably 
suppressive to the higher (25 X  106) dose (Fig. 4, groups V and VI). This time 
and allogeneic cell dose biphasic effect on T  cell function is fully concordant 
with  our previous  studies  demonstrating such  contrasting influences of  the 
allogeneic effect directly on B  cell  function (9).  Whereas it has been clearly 
established by appropriate controls that the enhancing influences of the allo- 
geneic  effect on  T  cell  priming  are  not  due  to  carry-over  and  subsequent 
effects of allogeneic cells  on DNP B  cells,  it has not been possible to devise 
similar  definitive  controls  for  the  suppressive  effects  discussed  above.  We 
interpret these data to indicate suppressive effects of allogeneic cells on helper 
T  cells; however, the possibility of suppression by allogeneic T  cells of DNP- 
primed B cells has not been ruled out. 
The allogeneic effect on T cell function may be mediated by either the direct 
interaction of donor T  cells with host T  lymphocytes, the interaction of donor 
T cells with host macrophages, or a combination of both of these, and represents 
the recognition of foreign histocompatibility antigens by the allogeneic T  cells, 
and their subsequent activation. These results cannot be accounted for by the 
carry-over of allogeneic lymphocytes with carrier-primed spleen cells and their 
ensuing interaction with DNP-specific B lymphocytes, i.e. the allogeneic effect 
on B  cells,  since  this possibility was ruled out by appropriate control groups 
(Figs. 2-5). The mechanism by which these activated allogeneic T lymphocytes 836  ALLOGENEIC  EFFECT  ON  T  CELL  FUNCTION 
increase the priming and subsequent functional capacity of the carrier-specific 
host T  cells is not clear, but the possibilities include: (a) the release of a mito- 
genie factor that would increase the number of antigen-specific cells in the host 
T  lymphocyte pool, (b) some direct effect that lowers the threshold of antigen 
triggering in host T cells during carrier priming, or (c) an acceleration of matura- 
tion of T  cell function. A possible role for the host macrophage in any of these 
postulated mechanisms cannot be ruled out by our studies, and may indeed be 
of crucial importance. The initiation of these mechanisms could require direct 
membrane-membrane  interaction,  the  release of soluble  mediators,  or both, 
and as a function of activated alloantigen-specific T  cells,  are most likely non- 
specific with respect to the carrier molecule. 
Regardless of the final elucidation of the mechanism involved, these studies 
clearly indicate that  the allogeneic effect may be a useful tool for regulating 
specific T  cell function operating in various parameters of cell-mediated im- 
munity. Bearing in mind the apparent balance that exists between enhancing 
and suppressive T cell influences on the immune system that is well exemplified 
by the  allogeneic effect, the question of applying this potential tool for non- 
specific suppression of the immune system to certain problems of autoimmunity 
merits  investigation.  Perhaps more likely is the utilization of the  enhancing 
influences of  the  allogeneic  effect as  a  potent  method  for  inducing  and/or 
increasing  specific T  cell-mediated immunity  against  relatively weak  tumor 
antigens. As mentioned above, promising results along these lines have already 
been obtained in guinea pigs inoculated with highly lethal L.2C leukemia (17, 
18). These findings together with the results of the present experiments demon- 
strating a clear influence of the allogeneic effect on T  cell function support the 
feasibility of utilizing such an approach to provide considerable benefit to an 
individual  harboring  an  actively growing  tumor.  Such  studies  are  currently 
underway in our laboratory using a variety of spontaneous and induced tumors 
in mice and rats. 
SUMMARY 
The studies presented herein were designed to directly evaluate the effects of 
a  transient GVH reaction on T  lymphocyte functions. To this end, we have 
shown that generation of carrier-specific helper cell function can be significantly 
influenced by the allogeneic effect. Thus,  carrier-primed helper cells derived 
from  CAF1  donor mice  were generally much  more  active in  specifically co- 
operating with syngeneic 2,4-dinitrophenyl (DNP)-primed B cells in adoptive 
recipients when parental A strain lymphocytes had been administered at some 
time  during  the priming regimen.  This was  true  when  allogeneic cells  were 
administered concomitantly with the initial priming dose of carrier protein as 
well as when the GVH was induced in animals that had been exposed to antigen 
several days previously. This indicates that the allogeneic enhancing effects can 
be manifested on either primed or unprimed  T  cell populations. The ultimate DAVID  P.  OSBORNE,  JR.  AND  DAVID  I-1. KATZ  837 
effect of the  GVH reaction on the development of helper  T  cell activity was 
found to be related to the number of allogeneic cells employed and the duration 
of  the  resultant  GVH  reaction  in  the  carrier-primed  host  animal.  Hence, 
allogeneic  stimulation  of  slightly  greater  magnitude  and/or  longer  duration 
resulted in marked suppression rather  than enhancement  of helper cell function 
in such donor mice. These  findings may have general relevance to problems in 
autoimmune diseases  and tumor immunity. 
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